Provided by Tiger Trade Technology Pte. Ltd.

Boundless Bio, Inc.

3.00
+0.10003.45%
Post-market: 2.94-0.0600-2.00%18:23 EDT
Volume:157.16K
Turnover:468.69K
Market Cap:68.24M
PE:-1.05
High:3.02
Open:2.91
Low:2.91
Close:2.90
52wk High:3.02
52wk Low:0.9612
Shares:22.75M
Float Shares:16.09M
Volume Ratio:1.11
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8563
EPS(LYR):-2.6027
ROE:-67.86%
ROA:-32.77%
PB:1.03
PE(LYR):-1.15

Loading ...

Boundless Bio to Merge with Serapha Bio, Restructure Operations

TIPRANKS
·
Jun 23

Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday

MT Newswires Live
·
Jun 23

Boundless Bio, Serapha Bio Sign Merger Deal With $230 Million Private Placement

MT Newswires Live
·
Jun 23

Boundless Bio to merge with Serapha Bio in all-stock deal, shares to trade as AATD

Reuters
·
Jun 23

Boundless Bio - Co and Serapha Bio Announce All-Stock Merger Agreement

THOMSON REUTERS
·
Jun 23

Boundless Bio - Combined Company Cash Expected to Fund Operations Into Second Half of 2029

THOMSON REUTERS
·
Jun 23

Boundless Bio - Deal Unanimously Approved by Both Boards; Expected to Close in Q4 2026

THOMSON REUTERS
·
Jun 23

Boundless Bio - Combined Company to Operate as Serapha Bio and Trade on Nasdaq as 'Aatd'

THOMSON REUTERS
·
Jun 23

Boundless Bio: Pre-Merger Boundless Bio Stockholders Expected to Own 3.7% of, Pre-Merger Serapha Stockholders Expected to Own 96.3% of Combined Co

THOMSON REUTERS
·
Jun 23

Press Release: Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

Dow Jones
·
Jun 23

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM

Reuters
·
Jun 23

Boundless Bio Shareholders Back Directors and Auditor Appointments

TIPRANKS
·
Jun 17

Boundless Bio shareholders elect Class II directors at annual meeting

Reuters
·
Jun 17

Boundless Bio Halts Early Cancer Trial, Resetting Expectations for BOLD

TIPRANKS
·
Jun 09

Boundless Bio publishes corporate presentation on ecDNA-directed cancer therapies

Reuters
·
May 09

Boundless Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Boundless Bio reports Q1 EPS (60c), consensus (56c)

TIPRANKS
·
May 08

Boundless Bio Q1 EPS $(0.60) Beats $(0.64) Estimate

Benzinga Earnings
·
May 08

Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights

GlobeNewswire
·
May 08

Boundless Bio Inc expected to post a loss of 58 cents a share - Earnings Preview

Reuters
·
May 05